. Author manuscript; available in PMC: 2017 Feb 1.

Published in final edited form as: Mol Cancer Ther. 2015 Dec 4;15(2):264–275. doi: 10.1158/1535-7163.MCT-14-0315

Table 1.

2-DG uptake of ³H-2-DG in HT-29 and MDA-MB-231 cancer cells and HUVEC and HMVEC(L)^*.

	Transport rate (nmol/mg protein +/− SD)

Cells	5 minutes	30 minutes
HT-29	5.2 +/− 0.69^**	21.4 +/− 0.67^***
MDA MB-231	4.1 +/− 0.09	19.2 +/− 0.91
HMVEC(L)	3.2 +/− 0.21	14.9 +/− 0.2
HUVEC	4.0 +/− 0.26	19.7 +/− 1.89

See methods section for description of experiments. HUVEC: Human Umbilical Vein Endothelial Cells; HMVEC(L): Human Lung Microvascular Endothelial Cells; MDA-MB-231: Human mammary Adenocarcinoma; HT-29: Human Colorectal Adenocarcinoma.

^**

p= 0.0086, HT-29 vs HUVEC; p= 0.0005, HT-29 vs. HMVEC.

^***

p= 0.002 HT-29 vs. HMVEC.